» Articles » PMID: 37126722

PGE Alters Chromatin Through H2A.Z-variant Enhancer Nucleosome Modification to Promote Hematopoietic Stem Cell Fate

Abstract

Prostaglandin E2 (PGE) and 16,16-dimethyl-PGE (dmPGE) are important regulators of hematopoietic stem and progenitor cell (HSPC) fate and offer potential to enhance stem cell therapies [C. Cutler , 3074-3081(2013); W. Goessling , 445-458 (2011); W. Goessling , 1136-1147 (2009)]. Here, we report that PGE-induced changes in chromatin at enhancer regions through histone-variant H2A.Z permit acute inflammatory gene induction to promote HSPC fate. We found that dmPGE-inducible enhancers retain MNase-accessible, H2A.Z-variant nucleosomes permissive of CREB transcription factor (TF) binding. CREB binding to enhancer nucleosomes following dmPGE stimulation is concomitant with deposition of histone acetyltransferases p300 and Tip60 on chromatin. Subsequent H2A.Z acetylation improves chromatin accessibility at stimuli-responsive enhancers. Our findings support a model where histone-variant nucleosomes retained within inducible enhancers facilitate TF binding. Histone-variant acetylation by TF-associated nucleosome remodelers creates the accessible nucleosome landscape required for immediate enhancer activation and gene induction. Our work provides a mechanism through which inflammatory mediators, such as dmPGE, lead to acute transcriptional changes and modify HSPC behavior to improve stem cell transplantation.

Citing Articles

The "Ins and Outs and What-Abouts" of H2A.Z: A tribute to C. David Allis.

Diegmuller F, Leers J, Hake S J Biol Chem. 2025; 301(2):108154.

PMID: 39761855 PMC: 11808731. DOI: 10.1016/j.jbc.2025.108154.


Multifunctional histone variants in genome function.

Wong L, Tremethick D Nat Rev Genet. 2024; 26(2):82-104.

PMID: 39138293 DOI: 10.1038/s41576-024-00759-1.


Profile of Leonard I. Zon.

Williams S Proc Natl Acad Sci U S A. 2023; 120(31):e2310767120.

PMID: 37467283 PMC: 10400938. DOI: 10.1073/pnas.2310767120.


PGE alters chromatin through H2A.Z-variant enhancer nucleosome modification to promote hematopoietic stem cell fate.

Sporrij A, Choudhuri A, Prasad M, Muhire B, Fast E, Manning M Proc Natl Acad Sci U S A. 2023; 120(19):e2220613120.

PMID: 37126722 PMC: 10175842. DOI: 10.1073/pnas.2220613120.

References
1.
Gavaravarapu S, Kamine J . Tip60 inhibits activation of CREB protein by protein kinase A. Biochem Biophys Res Commun. 2000; 269(3):758-66. DOI: 10.1006/bbrc.2000.2358. View

2.
Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S . Latent enhancers activated by stimulation in differentiated cells. Cell. 2013; 152(1-2):157-71. DOI: 10.1016/j.cell.2012.12.018. View

3.
Wu D, Sunkel B, Chen Z, Liu X, Ye Z, Li Q . Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer. Nucleic Acids Res. 2014; 42(6):3607-22. PMC: 3973339. DOI: 10.1093/nar/gkt1382. View

4.
Mieczkowski J, Cook A, Bowman S, Mueller B, Alver B, Kundu S . MNase titration reveals differences between nucleosome occupancy and chromatin accessibility. Nat Commun. 2016; 7:11485. PMC: 4859066. DOI: 10.1038/ncomms11485. View

5.
Perlin J, Sporrij A, Zon L . Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment. J Mol Med (Berl). 2017; 95(8):809-819. PMC: 5558790. DOI: 10.1007/s00109-017-1559-8. View